CEN/TC 140
Registration number (WIID) | Project No. | Title | Status |
---|---|---|---|
71064 | LVS EN ISO 20916:2024 | In vitro diagnostic medical devices - Clinical performance studies using specimens from human subjects - Good study practice (ISO 20916:2019) | Standarts spēkā |
68157 | LVS EN ISO 15189:2023 | Medical laboratories - Requirements for quality and competence (ISO 15189:2022) | Standarts spēkā |
74322 | LVS CEN ISO/TS 5798:2023 | In vitro diagnostic test systems - Requirements and recommendations for detection of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) by nucleic acid amplification methods (ISO/TS 5798:2022) | Standarts spēkā |
67464 | LVS CEN/TS 17811:2022 | Molecular in vitro diagnostic examinations - Specifications for pre-examination processes for urine and other body fluids - Isolated cell free DNA | Standarts spēkā |
27341 | LVS EN ISO 15193:2009 | In vitro diagnostic medical devices - Measurement of quantities in samples of biological origin - Requirements for content and presentation of reference measurement procedures (ISO 15193:2009) | Standarts spēkā |
68157 | EN ISO 15189:2022 | Medical laboratories - Requirements for quality and competence (ISO 15189:2022) | Standarts spēkā |
79016 | LVS EN ISO 15189:2022/A11:2023 | Medical laboratories - Requirements for quality and competence | Standarts spēkā |
65451 | LVS CEN/TS 17390-3:2020 | Molecular in vitro diagnostic examinations - Specifications for pre-examination processes for circulating tumor cells (CTCs) in venous whole blood - Part 3: Preparations for analytical CTC staining | Standarts spēkā |
61686 | LVS EN ISO 20186-3:2020 | Molecular in-vitro diagnostic examinations - Specifications for pre-examination processes for venous whole blood - Part 3: Isolated circulating cell free DNA from plasma (ISO 20186-3:2019) | Standarts spēkā |
75465 | CEN/TS 17981-2:2023 | In vitro diagnostic Next Generation Sequencing (NGS) workflows - Part 2: Human RNA examination | Standarts spēkā |
Displaying 41-50 of 272 results.